Hyperglycemia and advanced glycation end products (AGEs), via stimulation of NAPDH oxidase in pericytes, impair NO bioactivity and hence trigger pericyte contraction [25,26,27,28]. The gene discussed is FMO5; the disease is Hyperglycemia.